V001-1091 Screening compound: 1-[1-(cyclohexylmethyl)-1H-1,3-benzodiazol-2-yl]-N-{[3-(trifluoromethyl)phenyl]methyl}piperidine-3-carboxamide

V001-1091 Screening compound: 1-[1-(cyclohexylmethyl)-1H-1,3-benzodiazol-2-yl]-N-{[3-(trifluoromethyl)phenyl]methyl}piperidine-3-carboxamide
V001-1091 Screening compound: 1-[1-(cyclohexylmethyl)-1H-1,3-benzodiazol-2-yl]-N-{[3-(trifluoromethyl)phenyl]methyl}piperidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V001-1091
1-[1-(cyclohexylmethyl)-1H-1,3-benzodiazol-2-yl]-N-{[3-(trifluoromethyl)phenyl]methyl}piperidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V001-1091

Molecular Formula

C28H33F3N4O (C28 H33 F3 N4 O)

Compound Name

1-[1-(cyclohexylmethyl)-1H-1,3-benzodiazol-2-yl]-N-{[3-(trifluoromethyl)phenyl]methyl}piperidine-3-carboxamide

IUPAC name

1-[1-(cyclohexylmethyl)-1H-13-benzodiazol-2-yl]-N-{[3-(trifluoromethyl)phenyl]methyl}piperidine-3-carboxamide

SMILES

O=C(C(CCC1)CN1c1nc(cccc2)c2n1CC1CCCCC1)NCc1cccc(C(F)(F)F)c1

InChI

InChI=1S/C28H33F3N4O/c29-28(30,31)23-12-6-10-21(16-23)17-32-26(36)22-11-7-15-34(19-22)27-33-24-13-4-5-14-25(24)35(27)18-20-8-2-1-3-9-20/h4-6,10,12-14,16,20,22H,1-3,7-9,11,15,17-19H2,(H,32,36)/t22-/m0/s1

InChI Key

QFUXHPZIUUPJDA-QFIPXVFZSA-N

MDL Number (MFCD)

MFCD19968725

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

498.59

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

6.423

Distribution Coefficient, logD

6.422

Water Solubility, LogSw

-6.25

Polar Surface Area

37.699

Acid Dissociation Constant (pKa)

12.49

Base Dissociation Constant (pKb)

5.04

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

50.00

V001-1091 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

New Agro Library (44492 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases
Agro:
  • Agro

References: we are preparing a list of scientific research reports with V001-1091 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V001-1091?
Check Price and Availability of V001-1091, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V001-1091 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V001-1091
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V001-1091
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V001-1091 available by request